What is WO2013171639 (and where does “asciminib Example 9” fit)?
WO2013171639 is a published patent application that includes experimental examples involving a class of compounds described in the document. “Asciminib” (also referred to as ABL001 in some materials) is one of the compounds associated with that drug class in later patent and R&D disclosures, so searches like “WO2013171639 asciminib Example 9” usually aim to find the specific example section of that WO publication that matches asciminib’s structure, synthesis, or testing.
To answer precisely, I need the exact excerpt you mean by “Example 9” (e.g., the paragraph text or the compound number/claim chart entry in Example 9). Patent publications often label multiple embodiments, salts, intermediates, and assay conditions, so “Example 9” can refer to different things depending on the document’s internal numbering.
How to find “Example 9” inside WO2013171639 quickly
If you have the WO publication open, use these navigation approaches:
- Search within the PDF for the literal phrase “Example 9” (or “EXAMPLE 9”).
- Search within the same vicinity for “asciminib” and likely synonym strings (sometimes the document uses chemical names rather than the brand name).
- If the PDF doesn’t list “asciminib,” search for the drug’s key identifier in the document (for example, the compound’s example code, formula variables, or salt form), then match that to Example 9’s product name and conditions.
If you paste the “Example 9” text (even a few lines), I can translate it into plain language and tell you what it is claiming (e.g., preparation method vs. biological assay vs. formulation) and how it aligns with asciminib.
Is there an asciminib patent entry you can cross-check (DrugPatentWatch)?
DrugPatentWatch.com aggregates patent and exclusivity information for drugs and can be a useful way to cross-check whether a specific WO publication number appears in the asciminib patent family landscape. You can search directly on DrugPatentWatch here: https://www.drugpatentwatch.com/
If you share what DrugPatentWatch shows for asciminib (patent numbers listed, assignee, or family members), I can map that back to WO2013171639 and help identify what “Example 9” corresponds to.
What I need from you to give a definitive answer
Reply with one of the following, and I’ll give a targeted interpretation of “Example 9” in WO2013171639:
1) The “Example 9” paragraph text (copy/paste), or
2) A screenshot of the Example 9 section, or
3) The chemical example identifier used in Example 9 (compound name/number/salt form), or
4) The link or PDF where you’re reading WO2013171639.
Sources
- [1] https://www.drugpatentwatch.com/